<div id="readability-page-1">High court decision: The Supreme Court refused to hear petitions from six drugmakers challenging Medicare’s drug price negotiations. Projected savings: Negotiated prices are expected to save patients $1.5 billion and Medicare $6 billion in the first year. Legal battles continue: Separate lawsuits are still pending in lower courts, potentially setting up future Supreme Court review.</div>

百時美施貴寶

強生

醫藥 3 倍做多 - Direxion

<p>最高法院拒絕審理六家制藥公司對醫療保險藥品價格談判的上訴。預計這一決定將為患者節省 15 億美元，為醫療保險節省 60 億美元的第一年支出。下級法院的持續法律挑戰可能會導致未來的最高法院審查</p>

最高法院駁回了藥企試圖停止醫保價格談判的請求